Stock Market News for July 13, 2026
529 news published.
Defense & Aerospace
Boeing (BA) will spotlight global programs and partnerships at the Farnborough Airshow — an event that can influence order flows and backlog expectations. See the announcement.
CACI (CACI) said its SkyValor system was selected to strengthen drone defense at the U.S. southern border, a practical win that may drive near‑term contract revenue and follow‑on opportunities. Read the release.
Voyager (VOYG) was awarded a $298 million NASA contract following its completed Astrobotic acquisition — a sizeable government award that boosts backlog and validates space‑services consolidation strategies. Contract details: read more.
AeroVironment (AVAV) received MQ‑31A designation from the Italian Ministry of Defence, a validation that can accelerate European sales and export pathways for tactical unmanned systems. Read the notice.
AI, Cloud & Conversational Platforms
Cloudflare (NET) introduced Precursor, a one‑click behavioral defense aimed at stopping modern bots — a product that could widen security monetization and lower friction for enterprise adoption.
SoundHound AI (SOUN) was named a Leader in the 2026 Gartner® Magic Quadrant™ for Conversational AI Platforms — a positioning that can help sales motion and enterprise credibility in voice and conversational AI deals. Read the note.
RedCloud (RCT) unveiled CORE, an operating environment built on a $6.9 billion data foundation to unify trade intelligence and action — a strategic move to lock in enterprise workflows and data‑driven stickiness.
The Hackett Group (HCKT) established AI world‑class procurement benchmarks, a framework that could accelerate enterprise procurement transformations and help investors track companies with scalable, AI‑driven margin improvements. Read the release.
Commercial Rollouts & Fintech
Inter (INTR) launched wearables in the U.S., moving banking beyond the phone and targeting seamless payments and authentication on wrist and other devices — a product rollout that can expand user engagement and payment revenue streams. See the announcement.
First American Data & Analytics (FAF) brought one of the nation’s largest property datasets to ArcGIS, enabling decision‑ready GIS workflows that can deepen data monetization with geospatial customers. Read the release.
CitroTech (CITR) saw the City of San Diego expand a wildfire prevention program after a pilot that reduced encampment fires by 39% — a municipal win that can accelerate municipal rollouts and recurring service revenues. Read the notice.
Cosmos Health (COSM) continued open‑market repurchases, with the buyback reaching 4.36 million shares, signaling management confidence in cash flow and reducing share count amid its prescription‑medicine commercialization push in Greece. Read the update.
Dexcom (DXCM) received Health Canada authorization for the G7 15‑day sensor, extending continuous glucose monitor wear and continuity for Canadian adults. That approval can broaden international recurring revenue and supports adoption momentum for the G7 platform.
Earnings & Results
FB Financial Corporation (FBK) reported second‑quarter 2026 financial results — a regional bank earnings release that investors will parse for credit trends, loan growth and margin pressure in a higher‑rate environment. See the report.
Clorox (CLX) set an August 3 webcast for fourth‑quarter and fiscal‑year 2026 results — a heads‑up for consumer staples investors watching pricing, input costs and volume trends. Details: webcast notice.
Sanuwave Health (SNWV) reported preliminary Q2 revenue of $9.6–$9.8 million, above the high end of revised guidance — an upside that can stabilize sentiment for the small‑cap medical device name. Read the release.
Orchid Island Capital (ORC) published estimated Q2 2026 results and June 30 RMBS portfolio characteristics — an update that matters for mortgage‑REIT investors tracking yield, leverage and credit exposure. Read the announcement.
Aeroméxico (AERO) reported unaudited second‑quarter 2026 results — an airline earnings read that investors will use to assess capacity discipline, revenue per available seat mile and international demand trends. See the release.
Western Digital (WDC) and Tilray Brands (TLRY) announced upcoming fourth‑quarter and fiscal‑year 2026 results, with WDC set for August 5 and Tilray on July 28. These dates matter for investors watching inventory trends (WDC) and cannabis margin/volume dynamics (Tilray).
Big Pharma, Regulatory Approvals & Labels
Bristol Myers Squibb (BMY) reported FDA acceptance of the NDA for mezigdomide in relapsed/refractory multiple myeloma — acceptance reduces regulatory uncertainty and can act as a valuation catalyst ahead of advisory review. See the release.
BioMarin (BMRN) said the FDA accepted a supplemental NDA seeking full approval of VOXZOGO® (vosoritide) for children with achondroplasia — a label expansion that could materially increase commercial reach and revenue visibility. Read the filing.
Oncolytics Biotech (ONCY) reported an FDA regulatory milestone and strong randomized data in RAS‑mutant MSS colorectal cancer — clinical and regulatory progress that can shift development risk and partnership interest. See the update.
Clinical Progress & Trial Data
Incyte (INCY) presented Phase 1/2 multidose data for VGA039 showing meaningful bleed reductions in Von Willebrand disease — data supportive of a specialized hematology franchise. Details.
Cadrenal Therapeutics (CVKD) released late‑breaking Phase 2 data showing a greater than 25% reduction in thrombotic events in HIT with CAD‑1005 at ISTH 2026 — an efficacy signal with clear commercial and regulatory relevance. Read the abstract.
Voyager (VYGR) demonstrated a single IV dose of VY1706 reduced tau in GLP toxicology studies and expects a clinical start in H2 2026 — a preclinical‑to‑clinic milestone for neurodegeneration programs. Details.
NanoViricides (NNVC) received national ethics committee approval to start a Phase II trial of NV‑387 oral gummies for Ebola in Congo as outbreaks spread — a timely clinical move that, if successful, could open an urgent‑use therapeutic pathway and boost public‑health demand. Read the release.
Erasca (ERAS) updated preliminary Phase 1 data for ERAS‑0015, a pan‑RAS molecular glue, and laid out registration‑enabling plans in KRAS‑mutant solid tumors — a development that could position the program as a potential best‑in‑class candidate and attract partnership interest. See the release.
Biotech Financings & Capital Moves
Agenus (AGEN) closed an oversubscribed private placement of up to $340 million to advance registrational trials — a large financing that materially de‑risks development runway. Read the announcement.
Freedom Holding Corp. (FRHC) completed a US$300 million ordinary share offering — a balance‑sheet event that increases capital for growth but dilutes existing holders. See the filing.
Evotec (EVO) announced preliminary Q2 and H1 2026 results and updated its full‑year outlook — early financial reads that can clarify demand trends across drug‑discovery services and impact margins for contract‑research suppliers. Read the ad hoc release.
Erasca (ERAS) filed a proposed public offering of $500 million of common stock — a sizeable capital raise that could fund registrational plans but will be watched for dilution and timing relative to upcoming pivotal readouts. Read the filing.
Energy, Infrastructure & Renewables
Halliburton (HAL) won integrated drilling and completions contracts for the Granmorgu deepwater project offshore Suriname, supporting service‑sector visibility into offshore capex. Details.
Brenmiller Energy (BNRG) expanded its footprint in Hungary, advancing an industrial Energy Resource Center for BrenX — a regional build‑out that bolsters commercial adoption of thermal energy storage. Read the update.
General Fusion (GFUZ) became the first publicly listed fusion company — a landmark for advanced energy markets that could attract investor interest in long‑duration clean‑energy tech despite long commercial timelines. Read the filing.
Trex Company (TREX) upgraded its distribution network, raised full‑year guidance, and named Specialty Building Products as its sole national distribution partner — a move that tightens logistics, supports the guidance raise and can accelerate retail availability for the decking leader. See the upgrade and the partner announcement.
Fluence (FLNC) will provide U.S. domestic‑content SmartStack systems for the Avantus 800 MWh Rexford 2 project in Southern California — a concrete supply win that highlights domestic battery‑storage manufacturing and could accelerate project timelines. Read the release.
Dealmaking & Corporate Actions
Greenfire Resources (GFR) agreed to acquire Connacher Oil and Gas for C$1.277 billion and plans a rights offering to finance the deal — a transaction with clear dilution and balance‑sheet implications. Read more.
First Hawaiian (FHB) will acquire TriCo Bancshares and provided preliminary Q2 results — regional bank consolidation that could reshape local market share and cost structure. Announcement: details.
Wynnchurch Capital (FERG) announced the sale of FloWorks to Ferguson Enterprises for $1.6 billion — a sizable private‑equity exit that highlights consolidation opportunities in plumbing and industrial distribution. Read the release.
GH Power is set to go public through a business combination with Matinas BioPharma (ticker MTNB), a deal that brings a clean‑energy and critical‑materials company to public markets and may reshape investor access to battery‑supply related assets. See the filing.
Gold Royalty (GROY) will release second‑quarter 2026 results on August 5 and announced acquisitions of additional royalties — an active M&A cadence that can expand production‑weighted cash flow and influence near‑term sentiment for royalty investors.
Regulatory, Market Structure & Index Moves
BNB Plus Corp. (BNBX) announced a Nasdaq delisting determination and will seek review — a liquidity change that matters for holders and market access. Read.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement